Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis-Reference-Cited by-同舟云学术

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis

Published:2000-12 Issue:12 Volume:22 Page:1410-1420
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Adler Jay L,Jannetti William,Schneider David,Zhang Jie,Palmer Robert,Notario Gerard

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Chronic bronchitis and acute infectious exacerbations;Reynolds,2000

2. Bronchitis and asthma;Chodosh,1992

3. Role of infection in chronic bronchitis;Gump;Am Rev Respir Dis.,1976

4. Changes in the spectrum of organisms causing respiratory tract infections: A review;Kayser;Postgrad Med J.,1992

5. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease,1995

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection;Scientific Reports;2024-08-28

2. Compliance with Once-Daily versus Twice or Thrice-Daily Administration of Antibiotic Regimens: A Meta-Analysis of Randomized Controlled Trials;PLOS ONE;2015-01-05

3. Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin) and Glycylcyclines (Tigecycline);Medical Clinics of North America;2011-07

4. Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline;Infectious Disease Clinics of North America;2009-12

5. Role for 5‑day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis;Current Medical Research and Opinion;2007-01-23